These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32979560)

  • 21. Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies.
    Thase ME; Zhang P; Weiss C; Meehan SR; Hobart M
    Expert Opin Pharmacother; 2019 Oct; 20(15):1907-1916. PubMed ID: 31290344
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies.
    Nelson JC; Weiller E; Zhang P; Weiss C; Hobart M
    J Affect Disord; 2018 Feb; 227():103-108. PubMed ID: 29055257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder.
    Hobart M; Zhang P; Skuban A; Brewer C; Hefting N; Sanchez R; McQuade RD
    J Clin Psychopharmacol; 2019; 39(3):203-209. PubMed ID: 30946704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
    Sussman M; Yu J; Kamat SA; Hartry A; Legacy S; Duffy R; Aigbogun MS
    J Affect Disord; 2017 Jan; 207():54-62. PubMed ID: 27693466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian phase shifts and mood across the perinatal period in women with a history of major depressive disorder: a preliminary communication.
    Sharkey KM; Pearlstein TB; Carskadon MA
    J Affect Disord; 2013 Sep; 150(3):1103-8. PubMed ID: 23706877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between circadian measures, depression, and response to antidepressant treatment: A preliminary investigation.
    Swanson LM; Burgess HJ; Huntley ED; Bertram H; Mooney A; Zollars J; Dopp R; Hoffmann R; Armitage R; Todd Arnedt J
    Psychiatry Res; 2017 Jun; 252():262-269. PubMed ID: 28285255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder.
    Bauer M; Hefting N; Lindsten A; Josiassen MK; Hobart M
    Acta Neuropsychiatr; 2019 Feb; 31(1):27-35. PubMed ID: 30223911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Brexpiprazole on Prolactin and Sexual Functioning: An Analysis of Short- and Long-Term Study Data in Major Depressive Disorder.
    Clayton AH; Ivkovic J; Chen D; George V; Hobart M
    J Clin Psychopharmacol; 2020; 40(6):560-567. PubMed ID: 33136923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial.
    Lieverse R; Van Someren EJ; Nielen MM; Uitdehaag BM; Smit JH; Hoogendijk WJ
    Arch Gen Psychiatry; 2011 Jan; 68(1):61-70. PubMed ID: 21199966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies.
    Weiss C; Weiller E; Baker RA; Duffy RA; Gwin KK; Zhang P; McQuade RD
    Int Clin Psychopharmacol; 2018 Sep; 33(5):255-260. PubMed ID: 29878915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can the circadian phase be estimated from self-reported sleep timing in patients with Delayed Sleep Wake Phase Disorder to guide timing of chronobiologic treatment?
    Lovato N; Micic G; Gradisar M; Ferguson SA; Burgess HJ; Kennaway DJ; Lack L
    Chronobiol Int; 2016; 33(10):1376-1390. PubMed ID: 27611743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive Brexpiprazole: A Review in Major Depressive Disorder.
    McKeage K
    CNS Drugs; 2016 Feb; 30(2):91-9. PubMed ID: 26849053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of the phase angle between cortisol and melatonin in major depression - a potential biomarker?
    Buckley TM; Schatzberg AF
    J Psychiatr Res; 2010 Jan; 44(2):69-74. PubMed ID: 20004915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of the biological rhythms interview for assessment in neuropsychiatry: An item response theory and actigraphy analysis.
    Allega OR; Leng X; Vaccarino A; Skelly M; Lanzini M; Hidalgo MP; Soares CN; Kennedy SH; Frey BN
    J Affect Disord; 2018 Jan; 225():54-63. PubMed ID: 28787704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data.
    McIntyre RS; Therrien F; Ismail Z; Meehan SR; Miguelez M; Larsen KG; Chen D; MacKenzie EM; Thase ME
    J Psychiatr Res; 2023 Jun; 162():71-78. PubMed ID: 37099968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study.
    Robillard R; Carpenter JS; Feilds KL; Hermens DF; White D; Naismith SL; Bartlett D; Whitwell B; Southan J; Scott EM; Hickie IB
    Front Psychiatry; 2018; 9():624. PubMed ID: 30618853
    [No Abstract]   [Full Text] [Related]  

  • 38. Sini powder with paroxetine ameliorates major depressive disorder by modulating circadian rhythm: A randomized, double-blind, placebo-controlled trial.
    He X; Zhang R; Li Z; Yao Z; Xie X; Bai R; Li L; Zhang X; Zhang S; Shen Y; Li S; Hui Z; Liu R; Chen J
    J Pineal Res; 2022 Nov; 73(4):e12832. PubMed ID: 36073608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.
    Kishi T; Sakuma K; Nomura I; Matsuda Y; Mishima K; Iwata N
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):698-709. PubMed ID: 31350882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis.
    Yoon S; Jeon SW; Ko YH; Patkar AA; Masand PS; Pae CU; Han C
    J Clin Psychopharmacol; 2017 Feb; 37(1):46-53. PubMed ID: 27941419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.